비뇨의학 Urology Digest ISSN:2713-7910(Print) 2733-5453(Online)

Ng M et al., Benign prostatic hyperplasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 May]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558920/

Zhang H et al., High real-world medication adherence and durable clinical benefit in Medicare patients treated with 5-α-reductase inhibitors for benign prostatic hyperplasia, J Urol, 2020

Levy A et al., Benign prostatic hyperplasia: when to watch and wait, when and how to treat, Cleve Clin J Med, 2007

Halawani A et al., Risks and side effects in the medical management of benign prostatic hyperplasia, Prostate Int, 2024

Emberton M et al., Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management, Int J Clin Pract, 2008

Elterman D et al., Reimagining male lower urinary tract symptoms due to benign prostatic hyperplasia treatment: a new approach to first-line interventional therapy, Eur Urol Focus, 2025

Flanigan RC et al., Five-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study, J Urol, 1998

Wei JT et al., Urologic diseases in America project: benign prostatic hyperplasia, J Urol, 2005

Cindolo L et al., Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: a population-based cohort study, Eur Urol, 2015

Anderson JB et al., The progression of benign prostatic hyperplasia: examining the evidence and determining the risk, Eur Urol, 2001

Roehrborn CG et al., Serum prostate-specific antigen concentration predicts acute urinary retention and need for surgery in benign prostatic hyperplasia, Urology, 1999

Wendt-Nordahl G et al., Transurethral resection of the prostate: defending its leading position in benign prostatic enlargement, Minerva Urol Nefrol, 2009

Lynch M et al., Time to rebrand transurethral resection of the prostate? Curr Opin Urol, 2006

Rassweiler J et al., Complications of transurethral resection of the prostate: incidence, management and prevention, Eur Urol, 2006

Winograd J et al., Search trends in the treatment for benign prostatic hyperplasia: a 20-year analysis, Asian J Urol, 2024

Daniels JP et al., Trends in interest for benign prostatic hyperplasia surgery options using Google Trends, Prostate Cancer Prostatic Dis, 2024

Sandhu JS et al., Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2023, J Urol, 2024

Franco JVA et al., Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis, BJU Int, 2022

Sciacqua LV et al., Minimally invasive treatment in benign prostatic hyperplasia, Technol Cancer Res Treat, 2023

Lambertini L et al., Complication rate across minimally invasive surgical treatments: a systematic review, Prostate Cancer Prostatic Dis, 2024

Busetto GM et al., Minimally invasive surgical therapies for lower urinary tract symptoms: promise or panacea? Asian J Androl, 2024

Elterman D et al., New technologies for treatment of benign prostatic hyperplasia, Urol Clin North Am, 2022

Yang J et al., Efficacy and safety of water vapor thermal therapy for benign prostatic hyperplasia: a systematic review and meta-analysis, BMC Urol, 2023

Elterman D et al., Multicenter prospective registry of Rezūm water vapor therapy for benign prostatic hyperplasia, Urology, 2022

Siena G et al., Water vapor therapy (Rezūm) for lower urinary tract symptoms: early results of the first Italian multicentric study, World J Urol, 2021

McVary KT et al., Five-year outcomes of water vapor thermal therapy for benign prostatic hyperplasia: randomized sham-controlled trial, J Urol, 2021

Gupta N et al., Three-year outcomes of water vapor thermal therapy versus pharmacologic therapy in benign prostatic hyperplasia: MTOPS cohort, J Urol, 2018

Gravas S et al., 2023 EAU guidelines on male lower urinary tract symptoms: summary. Eur Urol, 2023

Sønksen J et al., Prostatic urethral lift versus TURP: 12-month BPH6 results, Eur Urol, 2015

Gratzke C et al., Prostatic urethral lift versus TURP: 2-year BPH6 results, BJU Int, 2017

McVary KT et al., Prostatic urethral lift for LUTS while preserving sexual function: randomized study, J Sex Med, 2014

Roehrborn CG et al., Five-year results of the prostatic urethral lift randomized study, Can J Urol, 2017

Baboudjian M et al., Pharmacologic and surgical retreatment after office-based BPH treatments: systematic review, Eur Urol Focus, 2023

Porpiglia F et al., Three-year follow-up of temporary implantable nitinol device for prostatic obstruction, BJU Int, 2018

Kadner G et al., Second-generation temporary implantable nitinol device in LUTS: two-year MT-02 results, World J Urol, 2020

Chughtai B et al., iTind nitinol device for LUTS due to BPH: multicenter randomized trial, Urology, 2021

Amparore D et al., Three-year results with second-generation iTind in benign prostatic obstruction, Prostate Cancer Prostatic Dis, 2021

Elterman D et al., Sexual function after iTind treatment for LUTS, J Endourol, 2023

Gilling P et al., Aquablation: image-guided robot-assisted water-jet ablation of the prostate, BJU Int, 2016

MacRae C et al., Aquablation of the prostate using the AQUABEAM system, Can J Urol, 2016

Gilling PJ et al., Five-year outcomes of Aquablation vs TURP, Can J Urol, 2022

Oumedjbeur K et al., Aquablation vs TURP: five-year WATER trial outcomes for 50-80 cm³ prostates, Can J Urol, 2023

Nguyen DD et al., WATER vs WATER II two-year update: Aquablation therapy in 30-150 cm³ prostates, Eur Urol Open Sci, 2021

Berjaoui MB et al., WATER vs WATER II five-year update: Aquablation therapy for 30-150 cm³ prostates, BJUI Compass, 2024

Gilling P et al., Aquablation versus TURP in BPH: the WATER randomized trial, J Urol, 2018

Kaplan SA et al., Two-year follow-up of the Optilume BPH catheter system (PINNACLE), Prostate Cancer Prostatic Dis, 2024

Kaplan SA et al., Optilume BPH catheter system: PINNACLE randomized sham-controlled trial, J Urol, 2023

McKenzie P et al., Critical appraisal of the Spanner prostatic stent, Med Devices (Auckl), 2011

Cambio AJ et al., Extended use of the Spanner temporary prostatic stent in catheter-dependent men, Adv Urol, 2022

Cerrato C et al., Prostatic stents: a narrative review of current evidence, Ther Adv Urol, 2024

Lama J et al., Recent advancements in prostate catheters and stents for benign prostatic hyperplasia, Curr Urol Rep, 2024